Coronavirus (COVID-19) Information and Resources

Information and resources on coronavirus (COVID-19)

Menu Toggle

Cochrane Oral Health Collaborating Center
at Penn Dental Medicine

Cochrane Oral Health Collaborating Center
at Penn Dental Medicine

Cochrane is a global independent not-for-profit network of more than 37,000 contributors from over 190 countries working together to produce trustworthy, up-to-date, accessible health information that is free from commercial sponsorship and other conflicts of interest and helps healthcare providers, policymakers, and patients, their advocates, and caregivers make well-informed decisions about health care. On January 24, 2011, the World Health Organization (WHO) awarded Cochrane a seat on the World Health Assembly, allowing the collaboration to provide input on WHO health resolutions. Since its inception, Cochrane has defined the methodological standards for conducting systematic reviews around the world.

Cochrane has more than 50 thematic groups across all areas of medicine, including one group specially dedicated to oral health. Cochrane Oral Health (COH) has curated a collection of more than 213 systematic reviews and meta-analyses for over 34 relevant clinical areas in dentistry. The 2020 Impact Factor for COH systematic reviews is 7.324. A review published by Cochrane Oral Health in 2018 and 2019 was cited, on average, 7.324 times in 2020 (the highest 2020 Journal Impact Factor in dentistry is 8.728).

The new Cochrane Oral Health Collaborating Center at Penn Dental Medicine is the first oral-health-oriented review group in the world outside the UK. As a primary goal, the Center will become the leader in the production of evidence synthesis to inform dental practice and oral health policy worldwide. The Center will also focus on extensive capacity building and training a new generation of evidence synthesis researchers who need to face the challenges of a global oral health field that demands trustworthy, continuously updated, and user-tailored syntheses of the best available evidence.

The creation of this new entity places Penn Dental Medicine at the center of the oral health evidence synthesis field globally, in alignment with our mission statement: “To transform global oral health and well-being through exceptional clinical care, innovation, education, and research.”


Dr. Alonso Carrasco-Labra, Director

Dr. Alonso Carrasco-Labra, a leading authority in evidence-based health care, is as an Associate Professor in the Department of Preventive & Restorative Sciences. Prior to coming to Penn Dental Medicine in October 2021, he served as Senior Director of the Department of Evidence Synthesis and Translation Research within the American Dental Association (ADA) Science and Research Institute and as Director of ADA’s Center for Evidence-Based Dentistry. He has served as clinical practice guideline and policy methodologist for the Pan-American Health Organization/World Health Organization (PAHO), the World Bank, the U.S. Food and Drug Administration (FDA), the American Gastroenterological Association (AGA), as well as the governments and health care agencies in Saudi Arabia, Spain, Dominican Republic, UK, Canada, Colombia, Chile, and other ministries of health worldwide. For many years, Dr. Carrasco-Labra has also been active in the Cochrane Collaboration, an independent global organization internationally recognized as the benchmark for high-quality information about the effectiveness of health care. Presently, he serves on Cochrane’s Oral Health Group, the Wounds Group, the Patient Reported Outcome Methods Group, and the GRADEing Group.


For further information on the Cochrane Oral Health Collaborating Center at Penn Dental Medicine, 
please contact
To learn how to support the Center, contact Elizabeth Ketterlinus, Vice Dean of Institutional Advancement,

Interested in attending Penn Dental Medicine? Admissions